Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

Credo stock is now up more than 180% so far this year, demonstrating that there are outstanding opportunities for investors ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

During today's call, I'll start with a brief overview of the product launches and foundational progress we made in 2024 and ...

Demand is soaring for CrowdStrike's cybersecurity solutions, but it might not lead to upside for its stock in 2026.

Valens Semiconductor ("Valens"), a leader in high-performance connectivity, today announced that it will host meetings with customers, analysts and investors at Consumer Electronics Show (CES) 2026 on ...